Impact of loading dose β-lactam therapy on outcomes of KPC-producing Klebsiella pneumoniae bloodstream infections in non-ICU patients: a real world study

Key Points

• This research examines the effects of loading dose β-lactam therapy on treatment outcomes for KPC-producing Klebsiella pneumoniae bloodstream infections in non-ICU patients.
• Conducted a real world study in non-ICU patients with KPC-Kp BSIs.
• Analyzed outcomes associated with β-lactam loading dose regimen.
• Evaluated microbiological clearance, ICU transfers, and hospital stay length.
• Faster microbiological clearance observed with loading dose regimen.
• Reduced need for ICU transfer noted among non-ICU patients.
• Shorter hospital stays reported without increased toxicity.
• Mortality showed a non-significant trend towards improvement.